DOI: https://doi.org/10.22263/2312-4156.2016.4.65
Minina E.S.
Pharmacoeconomic effectiveness of intradermal autoserotherapy in children with atopic bronchial asthma
Educational Establishment «Vitebsk State Order of Peoples’ Friendship Medical University», Vitebsk, Republic of Belarus
Vestnik VGMU. 2016;15(4):65-72.
Abstract.
Objectives. To evaluate the economic effectiveness of the intradermal autoserum therapy method in the treatment of children with atopic bronchial asthma and the necessity for pharmacotherapy after the provided inpatient treatment.
Material and methods. The study included three groups of children aged 5-16 years with atopic bronchial asthma; their treatment included: intradermal autoserotherapy (AS) (n=44), intradermal autoserotherapy combined with the basic treatment (AS+BMT) (n=51), the basic treatment (BMT) (n=15) alone.
In the course of the study the economic effectiveness of the autoserum therapy method in complex treatment of children with atopic bronchial asthma was evaluated. The need for drugs was assessed in six months after the discharge from the hospital Public Health Establishment «Vitebsk Regional Children’s Clinical Center».
Results. In the groups of children, who received only AS as well as AS+BMT, the need for drug therapy decreased in six months after the given treatment (p=0,000001). It should be noted that the complex treatment of children with atopic bronchial asthma using intradermal autoserum therapy is both economically justified and efficient (group AS+BMT–CE=1,34, group BMT–CE=0,97).
Conclusions. Intradermal autoserum therapy combined with basic medication turns out to be clinically and economically effective, allows to reduce drugs requirement when compared to the group of children without autoserum.
Key words: bronchial asthma, intradermal autoserotherapy, pharmacotherapy, economic effectiveness.
References
1. Ros Respirator O-vo, Pediatr Respirator O-vo. Natsional'naia programma «Bronkhial'naia astma u detei. Strategiia lecheniia i profilaktiki» [The national program «Bronchial asthma at children. Strategy of treatment and prophylaxis». 4-e izd ispr i dop. Moscow, RF: Original-maket; 2012. 182 р.
2. Akdis CA, Agache I, ed. Global atlas of asthma. European Academy of Allergy and Clinical Immunology; 2013. 179 р.
3. Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R et al. International consensus on (ICON) pediatric asthma. Allergy. 2012 Aug;67(8):976-97.
4. Zhernosek VF, Vasilevskiy IV, Novikova VI, Lyapikov SA, Gavrilenko LN, Kacherovskaya ER, sost; Belorus Med Akademiia Poslediplom Obrazovaniia, Belorus Gos Med U-t, Viteb Gos Med U-t, Grodn Gos Med U-t. Klinicheskie protokoly diagnostiki i lecheniia allergicheskikh zabolevanii u detei [Clinical protocols of diagnostics and treatment of allergic diseases at children]. Minsk, RB: Prof izd; 2014. 30 р.
5. Novikov DK, Vykhristenko LR, Smirnova OV. Autoseroterapiia allergicheskikh zabolevanii [Autoserotherapy of allergic diseases]. Allergologiia i Immunologiia. 2008;9(4):478-80.
6. Titova ND, Asiryan EG. Snizhenie urovnia IgE-antitel k allergenam posle autoseroterapii u detei s allergiei [Depression of level of IgE-antibodies to allergens after an autoserotherapy at children with an allergy]. Immunopatologiia Allergologiia Infektologiia. 2011;(1):78-86.
7. Shchepin OP, Gabueva LA. Organizatsiia i ekonomika predprinimatel'skoi deiatel'nosti v zdravookhranenii [The organization and economy of business activity in health care]. Moscow, RF: MTsFER; 2006. 432 р.
8. Natsional'nyi statisticheskii komitet Respubliki Belarus' [National statistical committee of Republic of Belarus]: [ofits sait] [Elektronnyi resurs]. Minsk, 1998-2016. Rezhim dostupa: http://www.belstat.gov.by. Data dostupa: 12.06.2016.
9. Fond sotsial'noi zashchity naseleniia [Fund of social protection of the population]: [ofits sait] [Elektronnyi resurs]. Minsk, 2006-2016. Rezhim dostupa: http://www.ssf.gov.by/priside/about/structure/vitebskdep/. Data dostupa: 13.06.16.
10. Varni JW, Seid M, Knight TS, Uzark K, Szer IS. The PedsQL 4.0 Generic Core Scales: sensitivity, responsiveness, and impact on clinical decision-making. J Behav Med. 2002 Apr;25(2):175-93.
11. Seid M, Limbers CA, Driscoll KA, Opipari-Arrigan LA, Gelhard LR, Varni JW. Reliability, validity, and responsiveness of the pediatric quality of life inventory (PedsQL) generic core scales and asthma symptoms scale in vulnerable children with asthma. J Asthma. 2010 Mar;47(2):170-7.
12. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliabilitity and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001 Aug;39(8):800-12.
13. Movchan KA, Glushanko VS, Plish AV; Viteb Gos Med Un-t. Metodiki raschetov effektivnosti meditsinskikh tekhnologii v zdravookhranenii [Techniques of calculations of efficiency of medical technologies in health care]: instruktsiia po primeneniiu № 159-1203: utv M-vom zdravookhraneniia Resp Belarus' 31 dek 2003 g. Minsk, RB; 2003. 23 р.
Information about authors:
Minina E.S. – postgraduate of the Chair of Clinical Immunology & Allergology with the course of the Faculty for Advanced Training & Retraning, Educational Establishment «Vitebsk State Order of Peoples’ Friendship Medical University».
Correspondence address: Republic of Belarus, 210023, Vitebsk, 27 Frunze ave., Educational Establishment «Vitebsk State Order of Peoples’ Friendship Medical University», Chair of Clinical Immunology & Allergology with the course of the Faculty for Advanced Training & Retraning. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Minina Elena S.
